News
Morning Overview on MSN1d
The first AI-generated drug enters clinical trials
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...
With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process.
Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug candidates to testing for safety and efficacy ...
In this Q&A from the 2025 Veeva R&D and Quality Summit, Ibrahim Kamstrup-Akkaoui, vice president of data systems innovation at Novo Nordisk, discusses simplifying system use through the company’s ...
The agency's two main review offices will work together to flexibly evaluate medicines for serious conditions that affect ...
Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...
In this way, when it comes to clinical trial development, PurpleLab Managed Services focuses on supporting clients who are ...
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate ...
Makary announced plans for a new rare disease pathway in an April episode of "The Megyn Kelly Show." The proposal follows ...
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell December 13, 2024 07:51 AM Eastern Standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results